Figure 4
From: Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer
The estimation of immunotherapy response, chemotherapy response and potential therapeutic drugs for gastric cancer. (A) TIDE scores of two metabolic subtypes in the TCGA-STAD cohort. (B) T cell dysfunction scores of two metabolic subtypes in the TCGA-STAD cohort. (C) T cell exclusion scores of two metabolic subtypes in the TCGA-STAD cohort. (D–H) The chemotherapy response of two metabolic subtypes for 5 common chemotherapy drugs.
